Atlas Arteria is a toll roads owner, operator, and developer.
The company owns five toll roads in France, Germany, and the United States.
This year, Atlas Arteria shares paid investors an unfranked annual dividend of 40 cents per share.
According to analyst predictions published on CommSec, Atlas Arteria is expected to pay 37 cents per share in 2027.
Based on today's share price, that equates to a dividend yield of 9.7%.
That's more than twice the average 4.2% yield delivered by the S&P/ASX 200 Index (ASX: XJO) last financial year.
Image source: Getty Images
How much is that in dividends?
If I bought $15,000 worth of Atlas Arteria shares today, I'd own 3,926 shares.
If the experts are right, and I were to receive 37 cents per share in dividends in 2027, that would equate to $1,452.62.
The experts have also provided a dividend prediction for 2028.
They expect Atlas Arteria shares to pay 44 cents per share in dividends.
On a $15,000 investment, that would give me $1,727.44 in dividends.
That equates to a dividend yield of 11.5%.
Do the experts recommend Atlas Arteria shares?
Atlas Arteria shares have paid 40 cents per share in annual dividends since 2022.
However, that doesn't guarantee anything about the future.
Before you buy a stock for income, you have to do your research and feel satisfied that the dividend yield is sustainable long term.
Before you start that process, let's take a look at some expert ratings on the stock.
Morgans has a hold rating on Atlas Arteria shares with a 12-month share price forecast of $4.74.
That implies about 24% potential upside ahead.
In a note, Morgans noted the possibility that IFM Investors might be back with another takeover offer.
IFM offered $4.75 per share in April, with a promise to increase it to $5.10 if its stake rose above 45% by the offer's closing date.
The Atlas Arteria board rejected the offer.
The offer period closed in July, by which point IFM has increased its stake from 34.5% to 67.4%.
Citi also has a hold rating on Atlas Arteria shares with a 12-month target of $4.80, implying 26% upside ahead.
RBC Capital has a sell rating with a $3.60 target, suggesting a 6% downside ahead.
Macquarie gives Atlas Arteria shares a buy rating with a $4.75 target.
Atlas Arteria share price snapshot
The Atlas Arteria share price has fallen 20% over 12 months and 37% over five years.
